We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
1
Walmart Inc
WMT
$870B
$353M 24.73%
8,832,552
-64,239
-0.7% -$2.64M
KO icon
2
Coca-Cola
KO
$354B
$57.2M 4.01%
1,279,177
+12,700
+1% +$585K
MSFT icon
3
Microsoft
MSFT
$2.9T
$43.3M 3.04%
212,757
-15,347
-7% -$2.79M
SPGI icon
4
S&P Global
SPGI
$127B
$41.4M 2.9%
125,500
+600
+0.5% +$180K
AMGN icon
5
Amgen
AMGN
$198B
$40.7M 2.85%
172,415
+125,988
+271% +$28.7M
AAPL icon
6
Apple
AAPL
$4.79T
$39.3M 2.76%
430,744
-43,560
-9% -$3.38M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$120B
$27.4M 1.92%
94,389
+1,477
+2% +$400K
PG icon
8
Procter & Gamble
PG
$348B
$26.8M 1.88%
224,317
-6,816
-3% -$795K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.18T
$24.2M 1.7%
340,940
-1,560
-0.5% -$105K
INTC icon
10
Intel
INTC
$517B
$19.7M 1.38%
329,392
+2,505
+0.8% +$150K
JNJ icon
11
Johnson & Johnson
JNJ
$616B
$19.7M 1.38%
140,080
-658
-0.5% -$95.9K
DIS icon
12
Walt Disney
DIS
$167B
$18.7M 1.31%
167,366
+4,152
+3% +$458K
BMY icon
13
Bristol-Myers Squibb
BMY
$124B
$16.1M 1.13%
273,939
+645
+0.2% +$38.6K
ADBE icon
14
Adobe
ADBE
$87B
$15.7M 1.1%
36,077
-432
-1% -$160K
LOW icon
15
Lowe's Companies
LOW
$115B
$15.3M 1.08%
113,473
+3,777
+3% +$431K
PYPL icon
16
PayPal
PYPL
$49B
$15.2M 1.07%
87,270
-18,520
-18% -$2.56M
CSCO icon
17
Cisco
CSCO
$443B
$14M 0.98%
299,381
+4,699
+2% +$206K
CRM icon
18
Salesforce
CRM
$134B
$13.7M 0.96%
73,055
+8,895
+14% +$1.5M
AMZN icon
19
Amazon
AMZN
$2.63T
$13.4M 0.94%
97,260
+1,160
+1% +$140K
INTU icon
20
Intuit
INTU
$77.8B
$13.4M 0.94%
45,282
+140
+0.3% +$38.4K
MXIM
21
DELISTED
Maxim Integrated Products
MXIM
$12.8M 0.9%
210,732
-900
-0.4% -$50.1K
JPM icon
22
JPMorgan Chase
JPM
$927B
$12.7M 0.89%
134,716
-715
-0.5% -$67.8K
CVX icon
23
Chevron
CVX
$384B
$12.6M 0.88%
141,386
-1,406
-1% -$126K
UNH icon
24
UnitedHealth
UNH
$392B
$12.5M 0.88%
42,337
-1,660
-4% -$476K
TFC icon
25
Truist Financial
TFC
$63.2B
$11.9M 0.84%
317,212
-60,753
-16% -$2.19M
1
2 3 4 5

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.